A nasal swab containing a test sample is mixed with a simple lab test. It contains a liquid mixed with gold nanoparticles attached to a molecule that binds to the novel coronavirus. If the virus is present, the gold nanoparticles turns the solution a deep blue color (bottom of the tube) and a precipitation is noticed. If it is not present, the solution retains its original purple color.
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis. The authors published their work last week in the American Chemical Society’s nanotechnology journal ACS Nano.
“Based on our preliminary results, we believe this promising new test may detect RNA material from the virus as early as the first day of infection. Additional studies are needed, however, to confirm whether this is indeed the case,” said study leader Dipanjan Pan, PhD, Professor of Diagnostic Radiology and Nuclear Medicine and Pediatrics at the UMSOM.
Once a nasal swab or saliva sample is obtained from a patient, the RNA is extracted from the sample via a simple process that takes about 10 minutes. The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein. This protein is part of the genetic sequence that is unique to the novel coronavirus. When the biosensor binds to the virus’s gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue.
“The accuracy of any COVID-19 test is based on being able to reliably detect any virus. This means it does not give a false negative result if the virus actually is present, nor a false positive result if the virus is not present,” said Dr. Pan. “Many of the diagnostic tests currently on the market cannot detect the virus until several days after infection. For this reason, they have a significant rate of false negative results.”
Dr. Pan created a company called VitruVian Bio to develop the test for commercial application. He plans to have a pre-submission meeting with the U.S. Food and Drug Administration (FDA) within the next month to discuss requirements for getting an emergency use authorization for the test. New FDA policy allows for the marketing of COVID-19 tests without requiring them to go through the usual approval or clearance process. These tests do, however, need to meet certain validation testing requirements to ensure that they provide reliable results.
“This RNA-based test appears to be very promising in terms of detecting the virus. The innovative approach provides results without the need for a sophisticated laboratory facility,” said study co-author Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at UMSOM.
Although more clinical studies are warranted, this test could be far less expensive to produce and process than a standard COVID-19 lab test; it does not require laboratory equipment or trained personnel to run the test and analyze the results. If this new test meets FDA expectations, it could potentially be used in daycare centers, nursing homes, college campuses, and work places as a surveillance technique to monitor any resurgence of infections.
In Dr. Pan’s laboratory, research scientist Parikshit Moitra, PhD, and UMSOM research fellow Maha Alafeef conducted the studies along with research fellow Ketan Dighe from UMBC.
Dr. Pan holds a joint appointment with the College of Engineering at the University of Maryland Baltimore County and is also a faculty member of the Center for Blood Oxygen Transport and Hemostasis (CBOTH).
“This is another example of how our faculty is driving innovation to fulfill a vital need to expand the capacity of COVID-19 testing,” said Dean E. Albert Reece, MD, PhD, MBA, who is also Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor, University of Maryland School of Medicine. “Our nation will be relying on inexpensive, rapid tests that can be dispersed widely and used often until we have effective vaccines against this pandemic.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- 65 children among 521 new COVID-19 cases, six fresh fatalities in Odisha
The State’s recovery rate currently stands at 98.68% while active cases account for 0.51% of total positive cases registered in the State.
- Liver Histopathological Analysis of 24 Postmortem Findings of Patients With COVID-19 in China
Although the pathologic investigation of liver injury was observed in a couple of cases in China, the detailed description of liver histopathologic and ultrastructural changes in a relatively larger ...
- Covid-19 Cases Shoot up Amid Festive Season, 246 Deaths Recorded in Last 24 Hours
The rise in Covid-19 cases comes at a time when several states have eased Covid-19 restrictions amid the festive season.
- Small portion of COVID-19 patients infectious long-term
In late December 2019, a novel pneumonia-like lung infection was reported in the Chinese province of Hubei. This, in turn, led to the ongoing coronavirus disease-19 (COVID-19) pandemic. COVID-19 is ...
- More evidence for worse COVID-19 outcomes in people with HIV
The global effect of COVID-19 is enormous, and the havoc wrought is ongoing. Measuring the effect of COVID-19 on mortality is challenging, and analyses based on adjusted excess deaths suggest that ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Visual detection of Covid-19
- Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2
Study: A smartphone-based visual biosensor for CRISPR-Cas powered SARS-CoV-2 diagnostics. Image Credit: CI Photos / Shutterstock.com. Background. Quantitative real-time polymerase ...
- Sung Tieu On Havana Syndrome
Tieu's film Moving Target Shadow Detection (2021), commissioned for this year’s Frieze Artist Award, investigates a mysterious condition ...
- Covid 19 Delta outbreak: Auckland woman hid in car boot and travelled to Northland
An Auckland woman subject to court-imposed conditions hid in the boot of a car and travelled to Northland in the latest Covid breach. The woman from Half Moon Bay in Auckland, travelled to Whangārei ...
- FinancialNewsMedia.com: Rapid Advancements of Innovative Antiviral - COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 11, 2021 /PRNewswire/ -- With the arrival of the COVID-19 virus, the antivirals market had all eyes watching the ongoing ...
- Rapid Advancements of Innovative Antiviral - COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
With the arrival of the COVID-19 virus, the antivirals market had all eyes watching the ongoing frenetic rush to find a cure or at least ...